Topics:
cyclooxygenase-2, arthritis, hemorrhage, ulcer, anti-inflammatory agents, non-steroidal, naproxen, cyclooxygenase-2 inhibitors, cost-effectiveness analysis, ...
Ann Intern Med. 2003;138(10):795-806. doi:10.7326/0003-4819-138-10-200305200-00007